These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36568758)
1. Evaluation of a digital health system (PAHcare™) for routine care of patients with pulmonary arterial hypertension: The CBS-PAH study protocol. Pérez Peñate G; Ochoa Parra N; Domingo Morera JA; Martínez Meñaca A; López Ramón M; Cadenas Menéndez S; León Marrero F; Gómara de la Cal S; Ghadban Garrido C; Royo Tolosana P; Martin Puentes J; Aldonza Aguayo R; Mahdavi H; Bacchini Jeanneret G; Escribano Subías P Front Public Health; 2022; 10():954487. PubMed ID: 36568758 [TBL] [Abstract][Full Text] [Related]
2. Assessing the clinical benefit, safety, and patient-reported outcomes with the use of the PAHcare™ digital platform in pulmonary arterial hypertension: a pilot study. Peñate GP; Parra NO; Morera JAD; Meñaca AM; Ramón ML; Menéndez SC; Marrero FL; de la Cal SG; Ghadban-Garrido C; Tolosana PR; Puentes JM; Aguayo RA; Mahdavi H; Jeanneret GB; Subías PE Front Public Health; 2024; 12():1335072. PubMed ID: 38435295 [TBL] [Abstract][Full Text] [Related]
3. Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with sarcoidosis-associated pulmonary hypertension (SAPH): a qualitative interview study. Currie BM; Davies EW; Beaudet A; Stassek L; Kleinman L; Baughman RP BMC Pulm Med; 2021 Nov; 21(1):365. PubMed ID: 34772372 [TBL] [Abstract][Full Text] [Related]
4. From Health-Related Quality of Life (HRQoL) of Patients with Pulmonary Hypertension to Patient Experience with the Care Received: Should We Be More Aware of Current Patient Needs? Martínez Meñaca A; Blanco Vich I; López Meseguer M; López Reyes R; Bedate Díaz P; Elías Hernández T; Fernández-Cuesta Peñafiel I; Fernández G; Álvez Liste A; Escribano Subías P Adv Ther; 2021 Apr; 38(4):1860-1875. PubMed ID: 33675523 [TBL] [Abstract][Full Text] [Related]
5. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related]
6. Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP). Stollfuss B; Richter M; Drömann D; Klose H; Schwaiblmair M; Gruenig E; Ewert R; Kirchner MC; Kleinjung F; Irrgang V; Mueller C J Med Internet Res; 2021 Oct; 23(10):e25163. PubMed ID: 34623313 [TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. Ivarsson B; Hesselstrand R; Rådegran G; Kjellström B Chron Respir Dis; 2019; 16():1479972318787906. PubMed ID: 30011997 [TBL] [Abstract][Full Text] [Related]
8. Sexual Health-related Quality of Life in Women with Pulmonary Arterial Hypertension: Compensating for Loss. Yee DC; Banerjee D; Vargas SE; Allahua M; Whittenhall ME; Perry N; Ventetuolo CE; Guthrie KM Ann Am Thorac Soc; 2022 Jul; 19(7):1122-1129. PubMed ID: 35119972 [No Abstract] [Full Text] [Related]
9. Adult patient access to electronic health records. Ammenwerth E; Neyer S; Hörbst A; Mueller G; Siebert U; Schnell-Inderst P Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012707. PubMed ID: 33634854 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design. Benza RL; Franco V; Aras MA; Spikes L; Grinnan D; Satler C Respir Res; 2022 Dec; 23(1):355. PubMed ID: 36527025 [TBL] [Abstract][Full Text] [Related]
11. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter. Rees S; Williams A JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974 [TBL] [Abstract][Full Text] [Related]
12. Healthcare resource utilization and costs for patients with pulmonary arterial hypertension: real-world documentation of functional class. Dufour R; Pruett J; Hu N; Lickert C; Stemkowski S; Tsang Y; Lane D; Drake W J Med Econ; 2017 Nov; 20(11):1178-1186. PubMed ID: 28762848 [TBL] [Abstract][Full Text] [Related]
13. Management of COVID-19 in Patients with Pulmonary Arterial Hypertension. Farmakis IT; Giannakoulas G Heart Fail Clin; 2023 Jan; 19(1):107-114. PubMed ID: 36435565 [TBL] [Abstract][Full Text] [Related]
14. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol. Newell S; Jordan Z JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009 [TBL] [Abstract][Full Text] [Related]
15. Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment. Mathai SC; Minai O; Sullivan SD; Lerner D; Levine D Respir Med; 2017 Jan; 122 Suppl 1():S23-S27. PubMed ID: 27890471 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines. Dinarti LK; Anggrahini DW; Lilyasari O; Siswanto BB; Hartopo AB Glob Heart; 2021 Apr; 16(1):23. PubMed ID: 34040936 [TBL] [Abstract][Full Text] [Related]
17. Critical Care Network in the State of Qatar. Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205 [TBL] [Abstract][Full Text] [Related]
18. A phase III wait-listed randomised controlled trial of novel targeted inter-professional clinical education intervention to improve cancer patients' reported pain outcomes (The Cancer Pain Assessment (CPAS) Trial): study protocol. Phillips JL; Heneka N; Lovell M; Lam L; Davidson P; Boyle F; McCaffrey N; Fielding S; Shaw T Trials; 2019 Jan; 20(1):62. PubMed ID: 30658657 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension: updates in epidemiology and evaluation of patients. Levine DJ Am J Manag Care; 2021 Mar; 27(3 Suppl):S35-S41. PubMed ID: 33710842 [TBL] [Abstract][Full Text] [Related]